459 related articles for article (PubMed ID: 12052032)
21. The endocannabinoid system in invertebrates.
Salzet M; Stefano GB
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):353-61. PubMed ID: 12052049
[TBL] [Abstract][Full Text] [Related]
22. Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids.
Di Marzo V; Bisogno T; De Petrocellis L; Melck D; Martin BR
Curr Med Chem; 1999 Aug; 6(8):721-44. PubMed ID: 10469888
[TBL] [Abstract][Full Text] [Related]
23. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V
Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630
[TBL] [Abstract][Full Text] [Related]
24. Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance.
Sugiura T; Kobayashi Y; Oka S; Waku K
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):173-92. PubMed ID: 12052034
[TBL] [Abstract][Full Text] [Related]
25. The cannabinoid receptors.
Howlett AC
Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():619-31. PubMed ID: 12432948
[TBL] [Abstract][Full Text] [Related]
26. Biochemistry of the endogenous ligands of cannabinoid receptors.
Di Marzo V; Deutsch DG
Neurobiol Dis; 1998 Dec; 5(6 Pt B):386-404. PubMed ID: 9974173
[TBL] [Abstract][Full Text] [Related]
27. CB(1) and CB(2) receptor-mediated signalling: a focus on endocannabinoids.
McAllister SD; Glass M
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):161-71. PubMed ID: 12052033
[TBL] [Abstract][Full Text] [Related]
28. Conformational memories and the endocannabinoid binding site at the cannabinoid CB1 receptor.
Barnett-Norris J; Hurst DP; Lynch DL; Guarnieri F; Makriyannis A; Reggio PH
J Med Chem; 2002 Aug; 45(17):3649-59. PubMed ID: 12166938
[TBL] [Abstract][Full Text] [Related]
29. Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response.
De Petrocellis L; Melck D; Bisogno T; Milone A; Di Marzo V
Neuroscience; 1999; 92(1):377-87. PubMed ID: 10392859
[TBL] [Abstract][Full Text] [Related]
30. Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission.
Gubellini P; Picconi B; Bari M; Battista N; Calabresi P; Centonze D; Bernardi G; Finazzi-Agrò A; Maccarrone M
J Neurosci; 2002 Aug; 22(16):6900-7. PubMed ID: 12177188
[TBL] [Abstract][Full Text] [Related]
31. Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes.
Savinainen JR; Järvinen T; Laine K; Laitinen JT
Br J Pharmacol; 2001 Oct; 134(3):664-72. PubMed ID: 11588122
[TBL] [Abstract][Full Text] [Related]
32. Endocannabinoids, hormone-cytokine networks and human fertility.
Maccarrone M; Falciglia K; Di Rienzo M; Finazzi-Agrò A
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):309-17. PubMed ID: 12052045
[TBL] [Abstract][Full Text] [Related]
33. Structure-activity relationships of anandamide, an endogenous cannabinoid ligand.
Khanolkar AD; Makriyannis A
Life Sci; 1999; 65(6-7):607-16. PubMed ID: 10462061
[TBL] [Abstract][Full Text] [Related]
34. Endogenous cannabinoid ligands--chemical and biological studies.
Mechoulam R; Ben Shabat S; Hanus L; Fride E; Vogel Z; Bayewitch M; Sulcova AE
J Lipid Mediat Cell Signal; 1996 Sep; 14(1-3):45-9. PubMed ID: 8906544
[TBL] [Abstract][Full Text] [Related]
35. From cannabis to cannabinergics: new therapeutic opportunities.
Goutopoulos A; Makriyannis A
Pharmacol Ther; 2002 Aug; 95(2):103-17. PubMed ID: 12182958
[TBL] [Abstract][Full Text] [Related]
36. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo.
Bisogno T; Melck D; Bobrov MYu ; Gretskaya NM; Bezuglov VV; De Petrocellis L; Di Marzo V
Biochem J; 2000 Nov; 351 Pt 3(Pt 3):817-24. PubMed ID: 11042139
[TBL] [Abstract][Full Text] [Related]
37. Ligand-receptor signaling with endocannabinoids in preimplantation embryo development and implantation.
Paria BC; Dey SK
Chem Phys Lipids; 2000 Nov; 108(1-2):211-20. PubMed ID: 11106792
[TBL] [Abstract][Full Text] [Related]
38. Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown.
Reggio PH
Curr Med Chem; 2010; 17(14):1468-86. PubMed ID: 20166921
[TBL] [Abstract][Full Text] [Related]
39. Relationships between eicosanoids and cannabinoids. Are eicosanoids cannabimimetic agents?
Burstein SH; Young JK; Wright GE
Biochem Pharmacol; 1995 Nov; 50(11):1735-42. PubMed ID: 8615850
[No Abstract] [Full Text] [Related]
40. Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling.
Egertová M; Cravatt BF; Elphick MR
Neuroscience; 2003; 119(2):481-96. PubMed ID: 12770562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
